Armenia vs North Macedonia: Protecting minority investors (DB06-14 methodology) - Score
Armenia
63.33
in 2013
North Macedonia
63.33
in 2013
Armenia rank
34th
North Macedonia rank
34th
Protecting minority investors (DB06-14 methodology) - Score over time
- Armenia
- North Macedonia
How they compare
Armenia currently reports 63.33 against 63.33 in North Macedonia, a difference of 0.
The two have swapped places 3 times across 9 shared years of data; in 2005 it was Armenia ahead.
Armenia ranks 34th and North Macedonia ranks 34th of 190 countries.
Across the 2 decades both report, Armenia averaged higher in 1 and North Macedonia in 1.
Head to head by decade
| Decade | Armenia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50 | 46 | 4 | Armenia |
| 2010s | 56.67 | 58.33 | 1.67 | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors (db06-14 methodology) - score, Armenia or North Macedonia?
- Armenia, at 63.33 against 63.33 in North Macedonia as of 2013.
- What is the difference in protecting minority investors (db06-14 methodology) - score between Armenia and North Macedonia?
- 0, with Armenia ahead.
- How many years of comparable data are there for Armenia and North Macedonia?
- 9 years are reported by both, from 2005 to 2013.
- How do Armenia and North Macedonia rank globally for protecting minority investors (db06-14 methodology) - score?
- Armenia ranks 34th and North Macedonia ranks 34th of 190 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for protecting minority investors benchmarks economies with respect to the regulatory best practice on the indicator set. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.